Echinacea: benefits, use and precautions

• Echinacea is one of the most studied plants for immune support during the cold season.
• Evidence is mixed: the most consistent finding is a modest reduction in the duration of common cold symptoms.
• Three species are used: Echinacea purpurea, E. angustifolia and E. pallida, with different compositions.
• Short courses are generally well tolerated, but precautions apply (allergies, autoimmune disease, immunosuppressive therapy).

Echinacea is a herbaceous plant native to North America, traditionally used by Great Plains peoples. Modern herbal practice mainly uses the flowering aerial parts of Echinacea purpurea and the root of E. angustifolia.

• Alkylamides, concentrated in the root and linked to activity on the endocannabinoid system.
• Caffeic acid derivatives such as cichoric acid and echinacoside, with antioxidant properties.
• Polysaccharides and glycoproteins studied for their interaction with immune cells.

Content varies widely with species, plant part, extraction method and harvest season, so two products can behave very differently.

Documented uses focus on mild upper respiratory infections: supporting defences during seasonal colds, reducing perceived symptom intensity and sometimes shortening their duration.

Systematic reviews reach cautious conclusions. Several trials report cold duration shortened by roughly half a day to a day and a half, while others find no difference from placebo. Much of this inconsistency comes from the variety of preparations tested.

• Shorter cold duration: moderate but inconsistent evidence.
• Prevention of respiratory infections: weak evidence.
• Influenza, allergies or wound healing: insufficient evidence.

Echinacea is traditionally taken at the very first signs of a cold, for a short period, rather than continuously over months.

• Tincture or hydroalcoholic extract, the most studied form for aerial parts.
• Capsules of standardised dry extract.
• Infusion of dried aerial parts.
• Syrups and sprays, often combined with elderberry or propolis.

Clinical trials mostly use standardised extracts equivalent to a few grams of dried plant per day, split into two or three doses, over five to ten days. Because concentrations differ, the manufacturer dosage remains the reference.

Reported effects are mainly digestive (nausea, stomach discomfort) and cutaneous (rash). Allergic reactions are possible, particularly in people sensitive to Asteraceae such as ragweed, chamomile or marigold.

Echinacea is not advised in autoimmune disease, under immunosuppressive treatment, after transplantation, or in children without medical advice.

Theoretical interactions exist with immunosuppressants and with drugs metabolised by cytochrome P450 liver enzymes. Ask a pharmacist if you follow a long-term treatment.

• Check the botanical species and plant part, clearly stated on the label.
• Prefer a standardised extract with marker content specified.
• Check origin, farming method and the absence of unnecessary additives.
• Be wary of spectacular claims: no plant replaces medical treatment.

Echinacea is a reasonable ally for short-lived colds, provided you choose a quality preparation and use it for short periods. It does not replace sleep, adequate nutrition, or medical advice when symptoms persist.